C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using effective Statins (CORVUS) - C2 -CORVUS

Study identifier:NIS-CHU-DUM-2009/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using effective Statins (CORVUS)

Medical condition

cardiovascular risk

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

1500

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 May 2009
Primary Completion Date: -
Study Completion Date: 01 Nov 2009

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria